​

Vicarious Surgical Stock (NYSE:RBOT)

ForecastRevenueOwnershipFinancialsChartTranscripts
Vicarious Surgical by TradingView

Previous Close

$2.71

52W Range

$2.44 - $18.97

50D Avg

$4.53

200D Avg

$6.85

Market Cap

$15.74M

Avg Vol (3M)

$112.70K

Beta

1.52

Div Yield

-

RBOT Company Profile

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

123

IPO Date

Sep 04, 2020

Website

RBOT Performance

RBOT Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-66.56M$-80.67M$-80.08M
Net Income$-63.22M$-71.07M$89.16M
EBITDA$-66.56M$-69.19M$7.30M
Basic EPS$-10.74$-14.70$20.77
Diluted EPS$-10.74$-14.60$20.99

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q3 25Nov 12, 25 | 4:30 PM
Q2 25Aug 12, 25 | 4:30 PM
Q1 25May 12, 25 | 4:30 PM

Peer Comparison

TickerCompany
INTSIntensity Therapeutics, Inc.
HYPDHyperion DeFi, Inc.
PIIIP3 Health Partners Inc.
QTTBQ32 Bio Inc.
MODDModular Medical, Inc.
BOLDBoundless Bio, Inc.
NXLNexalin Technology, Inc.
ITRMIterum Therapeutics plc
PSTVPlus Therapeutics, Inc.